Francisco J. Galvez-Diaz
Burgos, CL 09006, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Impact of CYP and ABCB1 Polymorphisms on Bortezomib-Induced Adverse Events in Multiple Myeloma.
Journal: Biomedicines
Published: March 04, 2026
Development and validation of a novel prognostic index for mantle cell lymphoma integrating TP53 mutations (MIPI53).
Journal: British journal of haematology
Published: July 24, 2025
Pharmacogenetic Biomarkers of Ibrutinib Response and Toxicity in Chronic Lymphocytic Leukemia: Insights from an Observational Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 23, 2025
Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice.
Journal: Blood
Published: February 08, 2024
Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study.
Journal: Blood cancer journal
Published: June 20, 2023
Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma.
Journal: Annals of hematology
Published: May 17, 2022
Liquid biopsy: a non-invasive approach for Hodgkin lymphoma genotyping.
Journal: British journal of haematology
Published: April 28, 2021
Use of eltrombopag after romiplostim in primary immune thrombocytopenia.
Journal: British journal of haematology
Published: September 29, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026